1. Home
  2. XBIO vs MOVE Comparison

XBIO vs MOVE Comparison

Compare XBIO & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • MOVE
  • Stock Information
  • Founded
  • XBIO N/A
  • MOVE 2018
  • Country
  • XBIO United States
  • MOVE United States
  • Employees
  • XBIO N/A
  • MOVE N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • XBIO Health Care
  • MOVE Health Care
  • Exchange
  • XBIO Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • XBIO 4.2M
  • MOVE 4.7M
  • IPO Year
  • XBIO N/A
  • MOVE 2021
  • Fundamental
  • Price
  • XBIO $4.08
  • MOVE $0.69
  • Analyst Decision
  • XBIO Hold
  • MOVE Buy
  • Analyst Count
  • XBIO 1
  • MOVE 1
  • Target Price
  • XBIO N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • XBIO 187.0K
  • MOVE 94.2K
  • Earning Date
  • XBIO 08-12-2025
  • MOVE 08-13-2025
  • Dividend Yield
  • XBIO N/A
  • MOVE N/A
  • EPS Growth
  • XBIO N/A
  • MOVE N/A
  • EPS
  • XBIO N/A
  • MOVE N/A
  • Revenue
  • XBIO $2,582,728.00
  • MOVE $1,013,000.00
  • Revenue This Year
  • XBIO $14.23
  • MOVE $1,460.71
  • Revenue Next Year
  • XBIO $7.14
  • MOVE $96.77
  • P/E Ratio
  • XBIO N/A
  • MOVE N/A
  • Revenue Growth
  • XBIO 5.63
  • MOVE N/A
  • 52 Week Low
  • XBIO $2.20
  • MOVE $0.51
  • 52 Week High
  • XBIO $5.27
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 61.16
  • MOVE 46.25
  • Support Level
  • XBIO $3.44
  • MOVE $0.66
  • Resistance Level
  • XBIO $4.46
  • MOVE $0.80
  • Average True Range (ATR)
  • XBIO 0.63
  • MOVE 0.07
  • MACD
  • XBIO 0.05
  • MOVE 0.01
  • Stochastic Oscillator
  • XBIO 54.79
  • MOVE 28.26

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: